Programmed cell death (apoptosis) is essential in many biological processes, such as embryonic development, immune response, tissue homeostasis, and normal cell turnover. Dysregulation of apoptosis has been an important factor in numerous human diseases, including autoimmune disorder, Alzheimer's and Hunting ton's diseases, heart ischaemia, and various types of cancer. How the apoptotic machinery overrides the cellular survival factors is largely unknown. Using genetic and biochemical approaches, we found that the IkappaB kinase complex (IKK), which is a key regulator of cell survival, is inactivated during cAMP and TNF-alpha induced apoptosis. Specifically, IKK is phosphorylated and inactivated by cAMP- activated protein kinase A. Furthermore, IKK is proteolyzed during TNF-alpha-induced apoptosis. This work is novel as it provides evidence that will delineate the molecular mechanisms by which the apoptotic machinery interplays with cellular survival factors, such as IKK, and should provide information critical to the development of novel strategies in regulating the process of apoptosis in human diseases. Two hypothesis-driven specific aims will be pursued to determine the mechanism through which the apoptotic machinery overrides the protection conferred by the IkappaB kinase and to establish the role of inactivation of the IkappaB kinase in the progression of apoptosis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092650-05
Application #
6937184
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Yassin, Rihab R,
Project Start
2001-09-01
Project End
2006-08-31
Budget Start
2005-09-20
Budget End
2006-08-31
Support Year
5
Fiscal Year
2005
Total Cost
$250,660
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Zhang, Jiyan; Bui, Truc N; Xiang, Jialing et al. (2006) Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain. Mol Cell Biol 26:1223-34
Liu, Jing; Yang, Dan; Minemoto, Yuzuru et al. (2006) NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta. Mol Cell 21:467-80
Zhang, Jiyan; Liu, Jing; Yu, Chenfei et al. (2005) BAD Ser128 is not phosphorylated by c-Jun NH2-terminal kinase for promoting apoptosis. Cancer Res 65:8372-8
Liu, Jing; Minemoto, Yuzuru; Lin, Anning (2004) c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24:10844-56
Yu, Chenfei; Minemoto, Yuzuru; Zhang, Jiyan et al. (2004) JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 13:329-40
Gupta, Sudhiranjan; Purcell, Nicole H; Lin, Anning et al. (2002) Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019-28
Tang, Fangming; Tang, Guilin; Xiang, Jialing et al. (2002) The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 22:8571-9